CD9 Plays a Role in Schwann Cell
Schwann cells migrate extensively during the development and regeneration of peripheral nerves. To populate the PNS during development, Schwann cells first migrate along axons at the outer surface of the developing nerve and then migrate perpendicular to the nerve axis into the axon bundles (Peters and Muir, 1959; Cravioto, 1965; Billings-Gagliardi et al., 1974; ZiskindConhaim, 1988) . Migrating Schwann cells may also play a role in axon growth and guidance during development (Keynes, 1987; Noakes and Bennett, 1987; Noakes et al., 1988) . Schwann cell migration is also a crucial and often limiting factor in recovery from PNS injuries and neuropathies (Williams et al., 1983; Hall, 1986a,b; Griffin et al., 1987; Fields et al., 1989; Fenely et al., 199 1; Guernard et al., 1992; Franklin and Blakemore, 1993) . Schwann cell migration in viva can occur on two substrates: axonal surfaces and extracellular matrix components. Thus, there are a number of candidate molecules that might regulate Schwann cell migration. During development and regeneration, migrating Schwann cells express elevated levels of adhesion molecules (Nicke and Schachner, 1985; Daniloff et al., 1986; Daston and Ratner, 199 l) , extracellular matrix molecules and their receptors Sanes et al., 1990; Lefcort et al., 1992; Sirronen et al., 1992; Jaakola et al., 1993 ) trophic factors and their receptors (Heumann et al., 1987; Taniuchi et al., 1987; Kanje et al., 1989; Acheson et al., 1991; Toma et al., 1992) ; proteases (Meier et al., 1989; Kiousssi et al., 1992) , and the growth and motility regulating protein GAP-43 (Curtis et al., 1992) . Of these molecules, NGF, ~75 NGF receptor, merosin, laminin, fibronectin, and N-cadherin have been shown to regulate Schwann cell migration (Baron-Van Evercooren et al., 1982; McCarthy et al., 1983; Longo et al., 1984; Le Beau et al., 1988; Letoumeau et al., 1991; Bailey et al., 1993; Anton et al., 1994a,b) . Thus, the temporal correlation between migration and elevated Schwann cell expression of various cell surface and extracellular matrix molecules is a useful indicator of which molecules may modulate Schwann cell migration. This indicator will, however, neither identify novel functional molecules nor implicate other known molecules not yet found in Schwann cells. To identify such functionally relevant molecules, we generated a panel of monoclonal antibodies (mAb) that modulate Schwann cell migration in two in vitro bioassays. These mAbs are referred to by the prefix SMRA, for Schwann cell migration regulating antibodies.
To generate mAbs against antigens that specifically modulate Schwann cell migration, mice were first tolerized to a homogenate of fibroblasts using the immunosuppressant drug cyclophosphamide and then immunized with a Schwann cell homogenate. One of the mAb, SMRA 1, from this fusion dramatically facilitates Schwann cell migration in vitro. SMRAl was found to recognize a 26 kDa Schwann cell surface glycoprotein known as CD9.
In the nervous system, CD9 is found on embryonic sensory, sympathetic, and motor neurons, adrenal chromaffin cells, PNS and CNS glial cells, retina, and on certain retinoblastoma and neuroblastoma cell lines (Boucheix and Benoit, 1988; MartinAlonso et al., 1992; Tole and Patterson, 1993) . It is present on rat Schwann cells as early as embryonic day 17. Recent studies on molecules that define positional information in the PNS have identified a putative epitope on CD9 that is expressed preferentially by Schwann cells in rostra1 rather than caudal nerves and ganglia (Suzue et al., 1990; Kaprielian and Patterson, 1993) . CD9 is also a major cell surface protein in various hematopoetic cells, including pre-B cells, platelets, and activated T lymphocytes (Jennings et al., 1990; Masellis-Smith et al., 1990) . In pre-B cells and platelets, CD9 regulates cell activation and aggregation, possibly through an association with an integrin (Slupsky et al., 1989) . In the process, mAbs to CD9 induce tyrosine phosphorylation and increases in intracellular calcium concentration in platelets (Boucheix et al., 1987; Favier et al., 1990; Seehafer and Shaw, 199 1; Kroll et al., 1992; Yatomi et al., 1993) . mAbs to CD9 also enhance neutrophil adhesion to endothelial cells (Forsyth, 199 1) . Furthermore, CD9 regulates cell motility in a variety of cell lines (Ikeyama et al., 1993) . CD9 could therefore regulate cell adhesion and cell motility in Schwann cells.
We report here that a mAb against CD9, SMRAl, stimulates Schwann cell migration on cryostat nerve sections and on living axons. SMRA 1 also induces an increase in intracellular calcium levels and in the tyrosine phosphorylation of several Schwann cell proteins. Such functional effects of CD9, as well as the differential expression of a putative CD9 epitope on Schwann cells, suggest that CD9 is an important regulator of Schwann cell behavior in the PNS.
Materials and Methods

Monoclonal antibodies to CD9
Antibody SMRAI is one of the panel of mAbs raised against Schwann cell antigens using the previously described cyclophosphamide immunosuppression paradigm . A BALB/c mouse was tolerized with an injection of 15 mg of protein from whole cell extracts of the rat 3T3 fibroblast cell line. Over the next 48 hr, three injections of cyclophosphamide were administered at 100 mg/kg dosage at 14 hr intervals. The animal was tolerized with the same antigens and cyclophosphamide again at 14,42, and 70 d. Two weeks after the second tolerization procedure (day 28) the animal was immunized with 20 mg of protein from whole cell extracts of the mouse B 1.1 Schwann cell line. The B1.l cell line was generated by immortalizing primary mouse Schwann cells from neonatal sciatic nerve with a transforming retrovirus (B. Yankner and W. D. Matthew, unpublished observations). The immunization procedure was repeated again at 56 and 84 d. Three days after the final immunization (day 87) the mouse was sacrificed and hybridomas were made from its spleen as described by Matthew and Sandrock (1987) . Hybridomas grown in RPMI/lO% fetal calf serum media were subcloned repeatedlv. SMRAl is a mAb of the IaM isotvpe. mAbs ROCAl, ROCA2: and B2Cll have been previousl; described as specific to rat CD9 (Akeson and Warren, 1984; Kaprielian and Patterson, 1993; Kaprielian et al., 1994) and are of the IgG isotype.
Immunoprecipitation, electrophoresis, and immunoblotting Triton X-1 OO-soluble fractions of adult rat sciatic nerve membranes or S-16 Schwann cell membranes (Goda et al., 199 1) were prepared and CD9 was immunoprecipitated from these extracts, using a protein Gsepharose column and the SMRAl mAb, as described by Kaprielian and Patterson (1993) . An anti-mouse IgM mAb of the IgG isotype (Boehringer-Mannheim) was used to bind the SMRAl-CD9 complex to the orotein G-sepharose column. Pure CD9 is a gift from Dr. Z. Kapriehan. Platelet extracts were prepared as described by Boucheix et al. (1983) .
One-dimensional SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to the method of Laemmli (1970) on 10% polyacrylamide gels. All samples were run under nonreducing conditions. Following transfer to nitrocellulose (0.45 pm, Bio-Rad), protein bands were detected by immunoblotting.
The transfer was performed overnight using a BioIRad minigel transfer apparatus; the blots were then blocked for 30 min in Tris-buffered saline (TBS: 0.9% NaCl. 20 mM Tris-HCI, pH 7.4) containing 5% nonfat dry milk (Carnation) at room temperature. The blocked nitrocellulose was incubated for 3 hr at room temperature with hybridoma supematants from one of the following mAbs: ROCA 1, ROCA2, B2C 11, and SMRA 1. After three 15 min washes in TBS/O.S% Tween-20 (TBST), blots were incubated for 1 hr with I:100 biotinylated goat anti-mouse IgG or IgM (Vector) in blocking solution. Blots were then washed three times in TBST and incubated for 45 min with avidin-biotinylated horseradish peroxidase solution (ABC kit, Vector). After the final incubation, blots were washed twice in TBST and once in TBS prior to detection of bound antibodies with 0.05% diaminobenzidine (DAB) in 0.03% hydrogen peroxide. The reaction was stopped after 15 min by transferring the blots to distilled water.
Immunohistochemistry
Primary Schwann cells from one day rat sciatic nerve were dissociated and cultured in RPMI/ 10% FCS medium as described by Brockes et al. (1979) . After 2 d in culture, cells were incubated live in hybridoma supematant for 1 hr at room temperature. After three 5 min rinses in RPMI/ 10% FCS at room temperature, the cells were incubated in fluorescein-conjugated goat antiserum to mouse immunoglobulins (I:50 dilution in RPMI/lO% rat serum; Antibodies Inc.) for 45 min at room temperature. Following three 5 min rinses in RPMI/lO% FCS at room temperature, cells were mounted in the same medium for observation in a Zeiss epifluorescence microscope.
In some experiments, fresh-frozen 15 pm cryostat sections of normal or denervated sciatic nerves collected on gelatin-coated slides were stained with SMRA 1.
Bioassays for Schwann cell migration
In vitro bioassay to study Schwann cell migration on cryostat tissue sections. Thoracic level, dorsal root ganglia (DRG) were removed from 1 d Sprague-Dawley (Charles River) rat pups and placed in ice-cold RPM1 medium (GIBCO) supplemented with 10% fetal calf serum (FCS, Hyclone). After dissecting away blood vessels and nerve rootlets, ganglia were treated with 0.03% collagenase (Sigma) and 0.25% trypsin (Sigma) in RPM1 medium for 30 min at 37°C. Subsequently, DRGs were incubated with 0.01% DNase (Sigma) and 0.25% anti-trypsin (Sigma) in RPMI/lO% FCS medium for 15 min at 37°C. After two rinses in RPMI/ 10% FCS medium, DRGs were explanted onto 22 pm longitudinal cryostat sections of normal or denervated sciatic nerves (the latter are distal stumps of sciatic nerves transected in vivo 7 d prior to use).
Explants were cultured for 72 hr in a 50:50 mixture of RPMI/IO% FCS medium and hybridoma supematant. Schwann cells migrating out of the DRG explant onto nerve substrates were then visualized by incubating the cultures with 10 mM 5,6-carboxyfluorescein diacetate succinimidyl ester (Molecular Probes Inc.) in TBS for 5 min at room temperature. Cultures were immediately examined in a Zeiss microscope equipped with an epifluorescence filter. Images of these cultures were collected onto an optical disk drive and the extent of Schwann cell migration was measured using the IMAGE 1 program (Universal Imaging Inc.). A rectangular grid divided into several 100 pm2 squares was pasted on to each of these images, and the shortest distance between the edges of the DRG and the leading Schwann cells was measured. An average ofthese measurements indicates the mean maximum distance Schwann cells have migrated on a particular substrate from a particular DRG explant. Measurements from different experimental groups were statistically analyzed for differences using Student's t test (confidence interval = 95% or higher).
In a number of experiments, pieces of sciatic nerve from neonatal day 1 rats, instead of DRGs, provided the source of migrating Schwann cells. Sciatic nerves were removed from rat pups, cut into -1 mm pieces using a micro dissecting scissors, and cultured for 48 hr on tissue culture mastic in RPMI/ 10% FCS medium to facilitate the emiaration of most of the fibroblasts from the nerve explants (Monisey et il., 199 1). Following this initial incubation, nerve explants were harvested and explanted onto appropriate nerve substrates as described above.
After carboxyfluorescein imaging, some coverslips were washed several times in PBS and stained with antibodies to SlOO (a Schwann cellspecific marker, Dako Corp.) or neurofilament (Sigma). Cultures were also counterstained with 10 PM bisbenzamide (Sigma) to stain nuclei.
In vitro bioassay to study Schwann cell migration on axonal surfaces. Sciatic nerves of adult, Sprague-Dawley rats were crushed in vivo two days prior to the removal of corresponding DRGs at levels L4, L5, and L6. Following removal, DRGs were incubated at 37°C in RPMI/NZ media (RPM1 + 0.5 mg/ml insulin, 10 mg/ml transferin, 0.63 &ml progesterone, 1.6 11 mg/ml putrescene, and 0.52 mg/ml sodium selenite) containing 0.25% collagenase type II (Sigma) for 1.5 hr. At the end of this incubation, DRGs were triturated (16 passages) with a fire-polished glass pipette and 0.025% trypsin was added to the cell suspension. After 15 min at room temperature, 80 &ml DNase, and 100 &ml soybean trypsin inhibitor were added to the suspension. Following one round of gentle trituration to break up the DRGs into small neuronSchwann cell clumps, cells were suspended in 15 ml of RPMI/ 10% FCS media and centrifuged for 10 min at 500 x g. The cell pellet was resuspended in RPMI/lO% FCS and plated on laminin (10 &ml)-coated 35 mm petri dishes (Falcon) at a density of 500 cells/dish. After 24 hr in culture, cells were placed onto a 37°C stage on a Hoffman modulation contrast optics microscope, and time-lapse recordings of Schwann cells migrating on neurites were made using video microscopy. After monitoring the baseline activity for 30 min, media with mAbs (5 &ml) were perfused into the culture and the effects of mAbs on Schwann cell migration rates, as well as the morphology of migrating Schwann cells and neurites, were Tyrosinephosphorylation assay. Dissociated Schwann cells, prepared from neonatal rat sciatic nerve as described above, were cultured at a density of 50,000 cells/well for 48 hr in 24 well culture dishes. The cells in each well were then incubated for 45 min with approximately 2 pg of SMRAl or SMRA5 (control mAb). Some of the wells were left untreated in RPMI/lO% FCS medium. The cells were then rinsed twice in RPM1 medium and harvested in 100 ul of boiling SDS-PAGE sample buffer (20% glycerol, 4% SDS, 0.125 M 'Tris, 0.0 1 &ml bromophenol blue, 10% 2-mercaptoethanol, pH 6.8) containing 0.5 mM vanadate. Twenty-five microliter samples were then loaded into each well of a 10% polyacrylamide, Bio-Rad minigel and run at 200 mV. Separated proteins were blotted onto nitrocellulose, blocked first with 4% calf serum containing 0.5 mM vanadate and then with 10% calf serum in TBS (pH 7.4) overnight at 4°C. Bands of protein containing phosphorylated tyrosine were identified using an anti-phosphotyrosine mAb (P3300; Sigma) or a rabbit polyclonal antiserum (ABl600, Chemicon) diluted 1:750 in 10% calf serum. As stated by the manufacturers, these antibodies react specifically with phosphotyrosine-containing molecules. Positive bands were visualized with an anti-mouse Vectastain ABC-HRP kit using diaminobenzidine (DAB) as a substrate for peroxidase. In some eiperiments, labeled protein bands were visualized with an enhanced chemiluminescence (ECL, Amersham) kit using luminol as the substrate for peroxidase.
Calcium imaging. Fluo-3 AM, a membrane-permeant calcium indicator that increases in fluorescence with increasing calcium concentrations, was used to monitor calcium changes induced in Schwann cells bv SMRAl. Primarv cultures of Schwann cells in a 35 mm petri dish were incubated with 2 ml of Opti-MEM medium (GIBCO) containing 10 PM Flue-3 acetoxymethyl ester (AM) (Molecular Probes Inc.) and the nonionic detergent pluronic acid F127 at 0.5 mg/ml. Heavy metals that might bind to Fluo-3 and interfere with its calcium sensitivity were chelated by adding 10 M Tetrakis (2-pyridyl methyl) ethylenediamine (TPEM to the incubation medium. After an hour of incubation at 37°C &to-3Lloaded cells were washed twice in Opti-MEM and placed onto a 37°C stage on a Zeiss microscope. Images of Fluo-3-labeled cells were collected every 1.25 min using the IMAGE 1 system, an SIT camera, a computer-controlled shutter on the UV light source, and an optical 
Results
Generation of mAbs to Schwann cell surface antigens Antibodies to Schwann cell antigens were generated using the cyclophosphamide immunosuppression paradigm described previously . Cyclophosphamide was used to suppress the immune response of mice to a 3T3 fibroblast homogenate; subsequently, animals were immunized with a B 1.1 Schwann cell homogenate. Our goal was to generate mAbs to Schwann cell surface antigens that are involved in cell migration. Since fibroblasts are known to migrate in peripheral nerve and are known to use ubiquitous molecules such as fibronectin for their migration, we hypothesized that tolerization with fibroblast antigens followed by immunization with Schwann cell antigens would bias the immune response in the desired direction, in this case, functionally relevant and possibly novel Schwann cell specific antigens. Antibodies were first screened immunohistochemically for their ability to recognize Schwann cell surface membranes on primary, rat Schwann cells and sciatic nerve sections. Positive mAbs were then screened for their effects on in vitro Schwann cell migration bioassays. One of the mAbs resulting from this fusion, SMRA 1, was found to label Schwann cell membranes strongly and to enhance the rate of Schwann cell migration in in vitro bioassays, thus implicating the SMRAl antigen as an important regulator of Schwann cell migration.
Characterization of the SMRA I antigen as CD9 Triton X-1 OO-soluble fractions of membrane fractions from B1.l or S-16 Schwann cell lines and adult sciatic nerve homogenates yielded strong SMRAl binding signals in dot blots, whereas no signal was detectable in the detergent insoluble fractions, suggesting that the SMRAl antigen is likely to be an integral membrane protein rather than a cytoskeletal or extracellular matrix molecule. The SMRAl antibody also bound strongly to purified CD9 in dot blots (data not shown). In an effort to identify the SMRA 1 antigen unambiguously, detergentsoluble membrane fractions from adult sciatic nerves or S-16 Schwann cells were immunoblotted with SMRAl mAb (Fig.  la,@ . SMRAl labels a 26 kDa band, identical in molecular weight to CD9. The same 26 kDa band is also labeled by three previously characterized CD9 mAbs, ROCA 1 (Fig. 1 b,e) , ROCA2 ( Fig. 1 c) , and B2Cll (Fig. lj) . In membrane extracts of platelets, a rich source of CD9, ROCA 1 and SMRA 1 recognize the identical 26 kDa band (Fig. lg,h ). SMRAl and B2Cll also recognize the identical 26 kDa band in immunoblots of pure CD9 (Fig.  l&j) . As in dot blots, SMRAl does not bind any protein bands in the immunoblots of Triton X-lOO-insoluble fractions from adult sciatic nerve (con., Fig. lk) .
In addition, when the SMRAl antigen was immunoprecipitated with the SMRAl mAb and immunoblotted with the ROCAl mAb, the 26 kDa protein is positively stained by ROCAl (Fig. 2) . Thus, both ROCAl and SMRAl recognize the same 26 kDa CD9 protein. Neither the antibodies to Schwann cell surface integrins nor anti-mouse immunoglobulins immunoprecipitated CD9.
Immunohistochemical localization of the SMRAI antigen In living, primary rat Schwann cells, surface membrane staining is observed with SMRAl mAb. Prominent labeling is observed on the cell soma region (Fig. 3a) . The leading edges of the Schwann cell bipolar processes also label (arrowheads, Fig. 3a) . When a freshly harvested cell pellet of S-16 Schwann cells was frozen, sectioned, and stained with SMRAl, labeling is seen only on the cell surface, not in the cytoplasm (data not shown). In fresh frozen, adult rat sciatic nerve sections, SMRAl labels both the outer Schwann cell membranes (Fig. 3c, arrowhead) , and the axoplasm (Fig. 3c, arrow) . Occasionally, abaxonal Schwann cell surface membrane or axonal surface membrane staining is observed. No specific staining is observed in the Schwann cell cytoplasm or in the myelin layers. We were unable to determine if endoneurial fibroblasts labeled with SMRAl in nerve sections. Treatment with secondary antibodies alone did not label primary Schwann cells or nerve sections.
The SMRAI antibody promotes Schwann cell migration on sciatic nerve sections Sections of frozen sciatic nerve provide an in vitro substrate related to what Schwann cells encounter during their migration in vivo. In order to determine if Schwann cells use cell surface CD9 for their migration, we studied the effect of two anti-CD9 mAbs on Schwann cell migration on nerve substrates. Briefly, DRGs from neonatal day 1 rats were explanted onto normal adult sciatic nerve sections and cultured in RPMI/lO% FCS containing mAbs for 72 hr. Migrating Schwann cells were then visualized with a vital dye, carboxy fluorescein. We have previously demonstrated that the primary biological event in this bioassay is Schwann cell migration, not neurite extension or fibroblast migration (Anton et al., 1994a) . Nearly all of the migrating cells in this assay (>95%) are Schwann cells, and neurite outgrowth is limited to lo-50 km around the DRG explant. In the presence of SMRAl antibody, the average maximum distance of Schwann cell migration is 9 18 f 42 wrn (n = 12), whereas the migration in the absence of mAbs is 37 1 rf: 17 pm (n = 10) or in the presence of a control mAb, SMRAS, is 366 + 30 pm (n = 6) ( Fig. 4a-c) . SMRAS recognizes a Schwann cell surface antigen that remains to be identified. In addition to the SMRAS control, a number of other mAbs that bind Schwann cell surfaces also do not affect migration (data not shown). Another anti-CD9 mAb, B2C11, also enhances migration to the extent of 848 + 109 Km (n = 10) (Fig. 4d) .
Since CD9 is expressed on PNS neurons as well as Schwann cells (Tole and Patterson, 1993 ) the effect of the SMRAl on glial migration from the DRG explant could be due to an indirect effect, via the neurons. This, however, is unlikely because SMRA 1 also promotes Schwann cell migration from sciatic nerve ex- mAbs to the migrating Schwann cell surface is essential for increased migration. The effect of SMRA 1 on migration is more prominent on a normal adult sciatic nerve substrate than on a denervated sciatic nerve substrate. For example, on a normal nerve substrate, a 150% enhancement was seen in the presence of SMRAl (when compared to the control mAb), whereas only a 79% enhancement was seen when denervated substrate is used instead.
The SA4RAl antibody promotes Schwann cell migration on living axons
The bioassay using nerve substrates mimics Schwann cell migration on extracellular matrix and basement membrane com- ponents. Schwann cells also migrate on axons, however. Therefore, we tested the ability of SMRAl to influence Schwann cell migration on living axons. Precrushed, adult DRGs were dissociated into small neuron-Schwann cell clumps (-100 pm in diameter) and cultured in RPMI/lO% FCS medium. Observation of cultures at various time points indicated that neurons in the clumps establish extensive neurite networks by lo-16 hr in culture. Schwann cells in the neuron-Schwann cell clumps subsequently migrate along these neurites. Schwann cells are easily identified initially, because of their bipolar morphology and later, by SlOO expression. After Schwann cells begin to migrate on neurites (approximately 24 hr), baseline Schwann cell morphology, migration rates, and attachment to neurites were monitored by video microscopy for 45 min prior to adding antibody to cultures. Exposure to SMRAl enhances Schwann cell attachment to the neurites and increases their migration rates. Two typical Schwann cells are shown in Figure Sa (arrows) in their basal state. The one on the left (Schwann cell 1) is attached to neurites on its bipolar ends whereas the one on the right (Schwann cell 2) randomly migrates on the axons at a rate of -8 pm/hr. Beginning from about 15 min after SMRAI perfusion, Schwann cell 1 moves downwards and eventually attaches strongly to the neurites (Fig. Stid) . During and after this period of increased attachment, enhanced lamellapodial activity is seen in this Schwann cell. The migration rate of Schwann cell b increased to -30 pm/hr after mAb exposure as it moved back and forth along the main neurite and one of its small branches (Fig. Stid) . No such changes in morphology or migration rates are observed after perfusion of culture medium devoid of mAbs or containing control mAbs that bind to other antigens on Schwann cell surface. Efforts to reverse the effects of SMRAl mAb by washing with mAb-free medium did not yield any changes in 1 hr after removal of mAbs.
In an effort to investigate if anti-CD9 mAbs cause enhanced affinity of Schwann cells to neurites, we added SMRAl mAb to cultures at 24 hr and evaluated the number of Schwann cells attached to neurites. An average of4.3 + 0.34 (n = 34) Schwann cells associate with neurites in the presence of SMRAl, compared to 2.43 f 0.26 (n = 30) in the presence of control mAb SMRAS, or 2.31 * 0.24 (n = 38) in RPMI/lO% FCS medium (Fig. 6) . It is likely that under control conditions most of the Schwann cells remained within the neuron-!Schwann cell clump, instead of migrating out along the neurites.
It is apparent from these in vitro bioassays that the anti-CD9 mAbs bind to the CD9 molecule on the Schwann cell surface and influence its rate of migration and adhesion. To begin an investigation of second messenger pathways that may mediate these effects, we studied the effect of SMRA 1 mAb on tyrosine phosphorylation and intracellular calcium.
The SMRAI mAb elicits a rise in internal calcium levels in Schwann cells Intracellular calcium levels before and after exposure to mAbs were monitored using a fluorescent calcium indicator, Fluo 3-AM. Images of Fluo 3-AM-loaded cells were recorded at one minute intervals using an SIT camera. After 15 min of baseline measurement, mAbs were perfused into the culture and changes in calcium levels recorded. Exposure to SMRAl leads to a 63 f 9% increase in Fluo 3-AM fluorescence, indicating a rise in internal calcium levels. This rise begins 12-15 min after the mAbs are pulsed in, and reaches its peak at about 35 min. Elevated calcium levels remain stable for 2-3 min, before returning to baseline levels by 50 min after stimulation (Fig. 7) . In a majority of the experiments, Fluo 3-AM primarily labels Schwann cell bodies, and thus most of the calcium changes observed occurs in the cell soma (Fig. 7~) . Occasionally, however, some of the bipolar processes are labeled, and in these cells, SMRA 1 -induced intracellular calcium increases in cell soma and processes precede morphological changes such as increased lamellapodial activity (Fig. 7~) . For example, arrows on the Schwann cell images from 35 and 40 min poststimulation panels (Fig. 7~) indicate the lamellapodia or membrane protrusions induced by the antibody exposure. Changes in intracellular calcium preceded these morphological changes ( Fig. 7a ; 5-30 min). Measurement of calcium levels in Schwann cells bathed in culture medium devoid of mAbs indicates that calcium levels do not change randomly (Fig. 7b) . Similarly, exposure to a control Schwann cell surface molecule antibody, SMRA6, did not alter internal calcium levels (Fig. 7b) .
Changes in Schwann cell protein tyrosine phosphorylation induced by SMRAI mAb Changes in protein tyrosine phosphorylation were monitored at various time intervals after antibody stimulation by immunoblotting cell extracts with antibodies to phosphotyrosine. After a.
b . 48 hr in culture, primary Schwann cells were incubated with SMRAI mAb for 5, 10, 15,25,35, and 45 min before collecting the cells for analysis. Since primary Schwann cells exposed to the antibody begin to display morphological changes by 45 min, we hypothesized that analysis at time intervals mentioned above should be sufficient to detect important tyrosine phosphorylation events induced by the mAb. Over this period, phosphorylation of proteins of 220, 210, 185, 170, SO, 75, 26, 28 , and 8 kDa increased substantially relative to the amount of phosphorylation of those proteins in cells left untreated or treated with the control mAb, SMRAS (Fig. 8a) . Protein phosphorylation was also observed with B2Cll by Hadjiargyrou and Patterson (personal communications). A 125 kDa protein was transiently phosphorylated 5 min after stimulation with SMRAl; phosphorylation of this protein returned to basal levels within another 5 min (Fig. 8b) . We did not detect any significant changes in dephosphorylation of proteins induced by SMRA 1, even with the enhanced chemoluminescence (ECL) method. In the preceding article Hadjiargyrou and Patterson (1994) demonstrate that immobilized, anti-CD9 mAbs modulate Schwann cell mitosis and adhesion. B2C11, the mAb that is mitotic in their experiments, is also a potent enhancer of Schwann cell migration in our assays. However, B2Cll produces its effect on migration at a concentration (100 r&ml) well below its minimal mitotic dosage. Soluble SMRAl mAb does not block or induce Schwann cell mitosis in cell proliferation assays (data not shown). Furthermore, ROCA2, a CD9 antibody without any demonstrable mitotic effect, also enhances migration in our assays. Thus, the enhanced migration we observe in our assays with CD9 antibodies is not an indirect result of increased Schwann cell mitosis. Nevertheless, CD9 could regulate both mitosis and migration of Schwann cells in vivo, where these two different Schwann cell behaviors are temporally separated. If the distribution of CD9 is also spatially separated, in terms of where it is expressed and the complexes it forms with other molecules, then it is not difficult to hypothesize that the temporal and spatial regulation of CD9 may modulate distinctly different behaviors (i.e., mitosis, migration, and myelination) in Schwann cells. CD9 is present in peripheral nerves during these different Schwann cell behaviors (Tole and Patterson, 1993; Kaprielian et al., 1994) . Precisely how CD9 might be modified to function as a modulator of these varied behaviors remains unknown. Interestingly, the mitotic effect of CD9 antibodies requires that the mAbs be immobilized, whereas the effect of the mAbs on migration could be elicited by soluble mAbs, indicating that CD9 can modulate different behaviors in the same cell under different circumstances.
A dynamic regulation of adhesion between Schwann cells, stores. In human platelets, both of these pathways are involved axons, and their surrounding matrix is likely to determine the in the calcium rise induced by anti-CD9 antibodies (Favier et migratory behavior of Schwann cells. Regulation of cell-subal., 1989) . How does this internal calcium rise lead to enhanced strate adhesion by CD9 may well be a component in the encell motility in Schwann cells? Kater et al. (1988) hypothesized hanced migration induced by CD9 antibodies. The ability of that there is an optimal level of intracellular calcium for cell CD9 mAbs to enhance Schwann cell migration on normal, adult motility and growth. It is possible that under the control consciatic nerve substrates that are generally not supportive of cell ditions in our assays, Schwann cells migrate slowly, partly as a adhesion or growth Bedi et al., result of suboptimal levels of intracellular calcium. The SMRA 1 1992; Anton and Matthew, unpublished observations), as well mAb stimulation may raise the intracellular calcium concenas the enhanced affinity between neurites and Schwann cells in tration closer to the optimal level and thus stimulate cell mithe presence of the SMRAl mAb, support this hypothesis. In previous studies, mAbs to CD9 have been shown to increase homotypic and heterotypic cell-cell adhesion of platelets, pre-B cells, and endothelial cells (Jennings et al., 1990; Masellis-Smith et al., 1990; Forsyth, 199 1) . Moreover, overexpression of CD9 in various non-neural cell lines suppressed cell motility (Ikeyama et al., 1993) . Taken together, these results strengthen the idea that CD9 is an important regulator of motility-related, adhesive events in the PNS.
What are the mechanisms whereby CD9 regulates Schwann cell migration? It is likely that the binding of SMRAl to CD9 on the Schwann cell surface triggers a cascade of intracellular events, resulting ultimately in changes in Schwann cell morphology and motility. SMRAl probably acts like the yet to be identified natural ligand of CD9. Alternately, SMRAl might block an inhibitory function of CD9, thus allowing Schwann cells to respond in a positive fashion to its environmental cues. Studies done in platelets are instructive in deciphering the cascade of intracellular events that follows the activation of CD9. In platelets, mAb binding to CD9 elicits phosphatidyl inositol biphosphate (PIP,) hydrolysis which eventually causes the release of calcium from internal storage organelles, activation of protein kinases, and increased cellular binding to cell adhesion molecules such as fibronectin (Seehafer and Shaw, 199 1; Kroll et al., 1992; Yatomi et al., 1993) . Similarly, mAbs to cell adhesion molecules Ll and N-CAM are also thought to influence a similar set of second messengers in neural cells during regulation of neural cell adhesion (Schuch et al., 1989) . In an effort to understand the signal transduction steps that connect the CD9-SMRAl mAb binding to the morphological and motility changes in Schwann cells, we examined two signal transduction events associated often with changes in cell shape and motility: protein tyrosine phosphorylation and changes in calcium concentration.
gration.
Although it is evident that the SMRAl mAb induces changes in intracellular second messenger systems, the interrelationship between these changes remains unclear. Since tyrosine phosphorylation changes were observed prior to [Ca2+], changes were evident, it is conceivable that the latter is a downstream effect of tyrosine kinase activity. Conversely, calcium or some other second messenger such as 1,2-diacylglycerol that have been generated from CD9 activation could also activate various tyrosine kinases. What is clear, however, is that tyrosine phosphorylation ofcellular components is an important element in the regulation of cell behavior (Ingraham and Maness, 1990; Ullrich and Schlessinger, 1990; Schaller et al., 1993) . In our studies, mAb SMRAl induces tyrosine phosphorylation of 220, 210, 185, 170, 80, 75, 26, 28 , and 8 kDa proteins. Another protein with molecular weight 125 kDa was transiently phosphorylated.
We have yet to characterize the tyrosine phosphorylated proteins beyond their molecular weights. However, several of these phosphorylated molecules could be important regulators of Schwann cell migratory behavior. For example, the 125 kDa and 70 kDa tyrosine phosphorylated proteins could be focal adhesion kinase p 1 25FAK and paxillin, respectively. Both are important focal adhesion-associated proteins that are thought to play crucial roles in cell adhesion, growth, shape, and motility (Burridge et al., 1992; Zachary and Rozengurt, 1992) . The 160 kDa protein could be an a-subunit of an integrin receptor, since the adhesive effect of CD9 has been shown to require an association with integrin receptors, and tyrosine phosphorylation of an integrin subunit could be a necessary step in this process (Slupsky et al., 1989) . Tyrosine phosphorylation of integrins has also been proposed as a mechanism for the regulation of integrin-extracellular matrix affinity, a process important for cell motility (Hynes, 1992) . Furthermore, mAb SMRAl appears to induce a transformation in Schwann cells from a quiescent, relatively nonmotile state to an actively motile state. In Schwann cells, several proteins have been shown to regulate cell differentiation from one behavioral state to another. Examples of such proteins include, c-j&. c-src, SCIP, ras, N-myc, pCD25, and neu. (Ridley et al., 1988; Hengerer et al., 1990; Monuki et al., 1990; Nikitin et al., 199 1; Pyykonen and Koistinaho, 199 1; Sano et al., 1991; Spreyer et al., 1991) . Of these, neu is of particular interest since it is a 185 kDa receptor-like phosphoglycoprotein with tyrosine kinase activity that is thought to be a transducer molecule for Schwann cell proliferation controlling signals such as GGF (Lonardo et al., 1990; Nikitin et al., 199 1; Marchionni et al., 1993) . Perhaps CD9-induced phosphorylation of such a molecule may play an important role in a Schwann cell's decision to divide or migrate in response to CD9. Thus, it will be of interest to know if the 185 kDa protein phosphorylated in our assays is neu.
In neurons, intracellular calcium mediates the transduction of environmental signals into motility and morphological responses by selectively influencing different components of the neuronal cytoskeleton (Forscher, 1989; Kater and Mills, 199 I) . In neural crest cells, changes in internal calcium levels influence both the degree of cell-cell adhesion and the onset of cell migration (Newgreen and Gooday, 1985; Doherty et al., 1991) . We provide evidence that CD9 mAb-induced changes in intracellular calcium influence neural crest-derived Schwann cells in an analogous manner. Using a calcium indicator, Fluo-3AM, which has been previously used to study intracellular Ca2+ changes in Schwann cells (Jahromi et al., 1992) we find that SMRAl increases intracellular Ca2+ by 63 + 9% within 35 min of stimulation. This gradual rise in calcium over minutes is typical of studies where antibodies are used to modulate intracellular calcium (Schuch et al., 1989; Hato et al., 1990) . The rise in internal calcium could be the result of activated cell surface calcium channels or release of calcium from internal Studies on molecules that define position in the nervous system have identified a putative epitope on CD9 as a molecular determinant of position in PNS (Suzue et al., 1990; Kaprielian and Patterson, 1993) . The generation of positional identities in the nervous system is likely to involve cell movement and cell adhesion. These behaviors are also important elements in accurate and efficient regeneration of mammalian peripheral nerves (Brushart, 1990 (Brushart, , 1993 . The evidence provided here and by Hadjiargyrou and Patterson (1994) indicate that CD9 is involved in cell movement, adhesion, and mitosis. Such functional effects of CD9 on Schwann cells suggest that CD9 could well play a role both in the generation of rostrocaudal positional identity in the developing PNS and in accurate nerve regeneration following injury. This idea could be tested in in vivo pertubation studies using these CD9 mAbs. In utero surgery could be used to expose the early developing PNS to the anti-CD9 antibodies while the nerve entubulation model could be used to study the effects of mAbs on peripheral nerve regeneration (Williams et al., 1983; Muneoka et al., 1990) . Such in vivo experiments will help in confirming the role of CD9 as an important functional regulator of Schwann cell behavior in the PNS.
